Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2387]

Rare pulmonary side effects of brigatinib often resolve without treatment discontinuation

Rare pulmonary side effects of brigatinib often resolve without treatment discontinuation

Rates of long-term opiate use rises in Medicare cancer survivors each year after diagnosis

Rates of long-term opiate use rises in Medicare cancer survivors each year after diagnosis

Untangling a cancer signalling network suggests new roadmap to tumour control

Untangling a cancer signalling network suggests new roadmap to tumour control

'I'm here for breast cancer. Why are you talking to me about my heart?'

'I'm here for breast cancer. Why are you talking to me about my heart?'

Mutational intensity influences a tumour's response to PD-1 immunotherapy

Mutational intensity influences a tumour's response to PD-1 immunotherapy

Less-invasive mastectomy safe for more breast cancer patients

Less-invasive mastectomy safe for more breast cancer patients

Risk of metastatic cancer increases in those who have diabetes

Risk of metastatic cancer increases in those who have diabetes

EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer

EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer

Demand growing for CV specialists trained to treat heart disease in cancer patients

Demand growing for CV specialists trained to treat heart disease in cancer patients

Tumour-selective angiotensin blockers may improve response to cancer immunotherapy

Tumour-selective angiotensin blockers may improve response to cancer immunotherapy

More from ecancer